BG61689B1 - Включени комплекси на n-етоксикарбонил-3-морфолино-сиднониминили негови соли, образувани с циклодекстринови производни,получаването им и съдържащи ги фармацевтични състави - Google Patents

Включени комплекси на n-етоксикарбонил-3-морфолино-сиднониминили негови соли, образувани с циклодекстринови производни,получаването им и съдържащи ги фармацевтични състави Download PDF

Info

Publication number
BG61689B1
BG61689B1 BG95531A BG9553191A BG61689B1 BG 61689 B1 BG61689 B1 BG 61689B1 BG 95531 A BG95531 A BG 95531A BG 9553191 A BG9553191 A BG 9553191A BG 61689 B1 BG61689 B1 BG 61689B1
Authority
BG
Bulgaria
Prior art keywords
molsidomine
cyclodextrin
ethoxycarbonyl
complex
morpholino
Prior art date
Application number
BG95531A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG95531A (bg
Inventor
Maria Vikmon
Jozsef Szejtli
Jozsef Gaal
Istvan Hermecz
Agnes Hovarth
Katalin Marmarosi
Gabor Hovarth
Iren Munkacsi
Original Assignee
Therabel Industries Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Industries Sa filed Critical Therabel Industries Sa
Publication of BG95531A publication Critical patent/BG95531A/bg
Publication of BG61689B1 publication Critical patent/BG61689B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG95531A 1990-03-28 1991-11-27 Включени комплекси на n-етоксикарбонил-3-морфолино-сиднониминили негови соли, образувани с циклодекстринови производни,получаването им и съдържащи ги фармацевтични състави BG61689B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
PCT/HU1991/000012 WO1991014680A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
BG95531A BG95531A (bg) 1993-12-24
BG61689B1 true BG61689B1 (bg) 1998-03-31

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
BG95531A BG61689B1 (bg) 1990-03-28 1991-11-27 Включени комплекси на n-етоксикарбонил-3-морфолино-сиднониминили негови соли, образувани с циклодекстринови производни,получаването им и съдържащи ги фармацевтични състави

Country Status (34)

Country Link
US (1) US5403840A (ko)
EP (1) EP0477315B1 (ko)
JP (1) JP2582497B2 (ko)
KR (1) KR950004705B1 (ko)
CN (1) CN1051080C (ko)
AT (1) ATE138656T1 (ko)
AU (1) AU638824B2 (ko)
BG (1) BG61689B1 (ko)
BR (1) BR9105136A (ko)
CA (1) CA2054188C (ko)
CZ (1) CZ287353B6 (ko)
DE (1) DE69119853T2 (ko)
DK (1) DK0477315T3 (ko)
ES (1) ES2090320T3 (ko)
FI (1) FI102460B1 (ko)
GE (1) GEP19991832B (ko)
GR (1) GR3020684T3 (ko)
HR (1) HRP920561B1 (ko)
HU (1) HU210921B (ko)
IL (1) IL97714A (ko)
LT (1) LT3394B (ko)
LV (1) LV10245B (ko)
MC (1) MC2185A1 (ko)
MD (1) MD679G2 (ko)
NO (1) NO179611C (ko)
OA (1) OA10029A (ko)
PL (1) PL165868B1 (ko)
RO (1) RO109649B1 (ko)
RU (1) RU2111216C1 (ko)
SI (1) SI9110908A (ko)
SK (1) SK279891B6 (ko)
TJ (1) TJ231R3 (ko)
UA (1) UA27226C2 (ko)
WO (1) WO1991014680A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
ITTO20120056A1 (it) * 2012-01-24 2013-07-25 Borla Ind Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) * 2013-05-29 2014-11-30 Borla Ind Connettore per linee medicali
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DK243084A (da) 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
ES2037385T3 (es) * 1988-01-14 1993-06-16 Akzo N.V. Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
HRP920561A2 (hr) 1994-04-30
LV10245A (lv) 1994-10-20
MD679G2 (ro) 1997-11-30
WO1991014680A1 (en) 1991-10-03
NO179611B (no) 1996-08-05
SK279891B6 (sk) 1999-05-07
NO914649D0 (no) 1991-11-27
LTIP386A (en) 1994-12-27
CN1051080C (zh) 2000-04-05
FI915569A0 (fi) 1991-11-26
HU901868D0 (en) 1990-08-28
SI9110908A (sl) 1998-06-30
HRP920561B1 (en) 1999-12-31
KR920701182A (ko) 1992-08-11
EP0477315A1 (en) 1992-04-01
CA2054188A1 (en) 1991-09-29
BR9105136A (pt) 1992-08-04
BG95531A (bg) 1993-12-24
NO914649L (no) 1991-11-27
ES2090320T3 (es) 1996-10-16
RO109649B1 (ro) 1995-04-28
OA10029A (en) 1996-10-14
CS85191A3 (en) 1991-11-12
ATE138656T1 (de) 1996-06-15
GR3020684T3 (en) 1996-10-31
JPH04506362A (ja) 1992-11-05
AU638824B2 (en) 1993-07-08
DE69119853D1 (de) 1996-07-04
MC2185A1 (fr) 1992-09-16
DE69119853T2 (de) 1996-10-10
US5403840A (en) 1995-04-04
RU2111216C1 (ru) 1998-05-20
PL165868B1 (pl) 1995-02-28
PL293022A1 (en) 1992-12-28
FI102460B (fi) 1998-12-15
NO179611C (no) 1996-11-13
IL97714A0 (en) 1992-06-21
LT3394B (en) 1995-09-25
CA2054188C (en) 1996-07-23
TJ231R3 (en) 1999-11-24
HUT58109A (en) 1992-01-28
LV10245B (en) 1995-08-20
DK0477315T3 (da) 1996-09-30
CZ287353B6 (cs) 2000-11-15
CN1056688A (zh) 1991-12-04
HU210921B (en) 1995-09-28
AU7574591A (en) 1991-10-21
FI102460B1 (fi) 1998-12-15
UA27226C2 (uk) 2000-08-15
EP0477315B1 (en) 1996-05-29
IL97714A (en) 1995-03-30
MD679F1 (en) 1997-02-28
KR950004705B1 (ko) 1995-05-04
JP2582497B2 (ja) 1997-02-19
GEP19991832B (en) 1999-11-05

Similar Documents

Publication Publication Date Title
ES2639537T3 (es) Composiciones que comprenden drospirenona y un complejo entre etinilestradiol y una ciclodextrina
US5244881A (en) Compositions based on imipyramine
JPH0819004B2 (ja) 徐放性医薬製剤
Bonferoni et al. Characterization of a diltiazem-lambda carrageenan complex
HU183430B (en) Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
BG61689B1 (bg) Включени комплекси на n-етоксикарбонил-3-морфолино-сиднониминили негови соли, образувани с циклодекстринови производни,получаването им и съдържащи ги фармацевтични състави
BG61974B1 (bg) Комплекси, включващи n-морфолино-n-нитрозоаминоацетонитрил ициклодекстрин
FI104882B (fi) Menetelmä 3-morfolinosydnoni-imiinin tai sen suolan tai tautomeerin ja syklodekstriinin tai syklodekstriinijohdannaisen inkluusiokompleksin valmistamiseksi
KR960003605B1 (ko) 경구용 오메프라졸 약제의 코어 조성물을 제조하는 방법
HU211906A9 (en) Inclusion complexes of n-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
JPH01287094A (ja) ダナゾール−シクロデキストリン包接化合物
WO2004019989A1 (fr) Compose d'inclusion a base de nateglinide
SK278809B6 (sk) Inklúzny komplex 3-morfolinosydnonimínu alebo jeho